You are here: Industry Insights > SARS-CoV-2

News List

Elixirgen Therapeutics Announces Dosing of First and Second Participants in its COVID-19 Vaccine Phase 1/2 Clinical Trial at Fujita Health University prnewswire
May 26, 2021
Elixirgen Therapeutics, Inc., today announced the dosing of the first and second participants in its COVID-19 vaccine Phase 1/2 Clinical Trial in Japan.
QIMR Berghofer researchers create drugs for Covid-19 pharmaceutical-technology
May 26, 2021
Researchers from QIMR Berghofer Medical Research Institute in Queensland, Australia, have created two new peptide-based drugs to potentially prevent and treat Covid-19.
Seegene introduces an exclusive diagnostic system for diagnosing COVID-19 variants at ECCMID prnewswire
May 25, 2021
Seegene Inc. , a biotechnology firm specializing in molecular diagnostics has once again been recognized for its unique system for diagnosing COVID-19 variants at this year's European Congress of Clinical Microbiology, the ECCMID.
empowerDX At-Home COVID-19 Testing Kit Receives EUA For Children Three Years And Older prnewswire
May 24, 2021
Clinical Enterprise, Inc. d/b/a empowerDX, today announced its at-home COVID-19 testing kit received FDA-emergency use authorization for children three years and older.
Risk for Post-COVID-19 Clinical Sequelae Examined in Adults drugs
May 21, 2021
The risk for developing new clinical sequelae is increased after the acute phase of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), according to a study published online May 19 in The BMJ.
New vaccine platform: 'Two-one replicon-and-VLP-minispike vaccine' against COVID-19 worldpharmanews
May 20, 2021
To stop the current SARS-CoV-2 pandemic, vaccines of high quality, safety, and efficacy are required. Scientists of the Paul-Ehrlich-Institut and the Ludwig Maximilian University at Munich have conceived in the laboratory a novel vector vaccine based ...
mRNA COVID-19 vaccination is immunogenic in the immunocompromised europeanpharmaceuticalreview
May 19, 2021
Research suggests patients who receive COVID-19 vaccines prior to a transplant and subsequent immunosuppression may be protected from the disease.
FDA outlines plan for making inspections more consistent going forward europeanpharmaceuticalreview
May 14, 2021
The new report shows over 8,000 planned inspections were postponed due to COVID-19 and outlines the FDA’s plan for a more consistent future state of operations.
Speeding new treatments worldpharmanews
May 11, 2021
A year into the COVID-19 pandemic, mass vaccinations have begun to raise the tantalizing prospect of herd immunity that eventually curtails or halts the spread of SARS-CoV-2. But what if herd immunity is never fully achieved - or if the mutating virus ...
Our immune systems blanket the SARS-CoV-2 spike protein with antibodies worldpharmanews
May 11, 2021
The most complete picture yet is coming into focus of how antibodies produced in people who effectively fight off SARS-CoV-2 work to neutralize the part of the virus responsible for causing infection. In the journal Science, researchers at ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page